LATEST INSIGHTS

Medicine shortages are now part of the day-to-day reality for Australian hospitals and pharmacies. When an essential medicine becomes constrained, the impact is immediate.

Stricter storage, cold-chain and governance rules mean clinical trial, Managed Access and Early Access medicines now rely on specialist depots across Australia and APAC.

At HL Pharma, packaging is a critical control point, not just a box around your product. Our validated solutions for +2 °C to +8 °C, +15 °C to +25 °C and below −20 °C combine qualified shippers, reusable and recyclable options, real-time temperature monitoring.

Transdermal scopolamine is an unregistered medicine in Australia. Access is available exclusively to healthcare professionals through the TGA Special Access Scheme (SAS) where clinically appropriate and when no suitable registered alternative exists.

The storage and distribution of clinical trial materials is one of the most demanding aspects of modern pharmaceutical research, requiring precision, compliance, and collaboration across the supply chain.

HL Pharma is proud to announce that we will be exhibiting at the Royal Australian and New Zealand College of Ophthalmologists (RANZCO) Congress 2025, taking place in Melbourne this November.